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Wnt-signaling is one of the most abundant pathways involved in processes such as cell-prolifer-
ation, -polarity, and -differentiation. Altered Wnt-signaling has been linked with several neuro-
developmental disorders including attention-deficit/hyperactivity disorder (ADHD) as well as
with cognitive functions, learning and memory. Particularly, lipoprotein receptor-related protein
5 (LRP5) or LRP6 coreceptors, responsible in the activation of the canonical Wnt-pathway, were
associated with cognitive alterations in psychiatric disorders. Following the hypothesis of Wnt
involvement in ADHD, we investigated the association of genetic variations in LRP5 and LRP6
genes with three independent child and adolescent ADHD (cADHD) samples (total 2,917 partici-
pants), followed by a meta-analysis including previously published data. As ADHD is more preva-
lent in males, we stratified the analysis according to sex and compared the results with the
recent ADHD Psychiatric Genomic Consortium (PGC) GWAS. Meta-analyzing our data including
previously published cADHD studies, association of LRP5 intronic rs4988319 and rs3736228
(Ala1330Val) with cADHD was observed among girls (OR = 1.80 with 95% CI = 1.07–3.02,
p = .0259; and OR = 2.08 with 95% CI = 1.01–4.46, p = .0026, respectively), whereas in boys
association between LRP6 rs2302685 (Val1062Ile) and cADHD was present (OR = 1.66,
CI = 1.20–2.31, p = .0024). In the PGC-ADHD dataset (using pooled data of cADHD and adults)
tendency of associations were observed only among females with OR = 1.09 (1.02–1.17) for
LRP5 rs3736228 and OR = 1.18 (1.09–1.25) for LRP6 rs2302685. Together, our findings suggest
a potential sex-specific link of cADHD with LRP5 and LRP6 gene variants, which could contribute
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to the differences in brain maturation alterations in ADHD affected boys and girls, and suggest
possible therapy targets.
KEYWORDS
attention-deficit hyperactivity disorder, gender, genetics, polymorphism, SNP
1 | INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD), a neurodevelopmen-
tal disorder, is one of the most common psychiatric and behavioral
disorders in children and adolescents, with more than 5% of the pedi-
atric population affected worldwide, often persisting into adulthood
(Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014; Thomas, Sanders,
Doust, Beller, & Glasziou, 2015). Although both the cause and patho-
physiology of ADHD are largely unknown, there is a growing body of
evidence supporting interactions of multiple genetic and environmen-
tal factors during early development thus providing a neurobiological
susceptibility to the disorder (Curatolo, D'Agati, & Moavero, 2010).
ADHD diagnosis in children and adolescents is more frequent in
boys than girls, with males being 2–4 times more likely to meet diag-
nostic criteria than females (Davies, 2014). Moreover, age-at-onset,
severity, and comorbidities were found to be sex-dependent (Davies,
2014). Just recently, a fMRI study reported significant volume reduc-
tion in putamen and thalamus of girls with ADHD, whereas a signifi-
cant subcortical volume reduction was observed in ADHD patients
independent of sex (Rosch et al., 2018). Subsequently, the authors dis-
cuss the importance to study the trajectories of such neurodevelop-
mental disorders together with the sex-dimorphic neuroanatomical
development, as maturation timelines between boys and girls are sub-
stantially different (Rosch et al., 2018). Differential susceptibility to
pre- and postnatal stress has been discussed to affect brain develop-
ment and maturation in a sex-dimorphic manner, which was hypothe-
sized to add to the genetic load that already leads to the different
ADHD frequencies between genders (Van den Bergh et al., 2017).
The aforementioned recent findings as examples, point to the impor-
tance of studying genetic susceptibility for ADHD not only at the
diagnostic level, but also at age-at-onset and sex differences.
Wnt-signaling pathways orchestrate cellular proliferation, polarity
and differentiation; processes that are crucial for healthy tissue mor-
phogenesis, especially in the embryonic stage (MacDonald, Tamai, &
He, 2009). Two most known Wnt-pathways exist: a canonical path-
way and a noncanonical pathway. In the canonical pathway, the
secreted Wnt glycoproteins bind to Frizzled receptors, as well as to
either lipoprotein receptor-related protein 5 (LRP5) or LRP6 corecep-
tors, to initiate a signaling cascade, in which downstream β-catenin is
harnessed as a cotranscription factor in the nucleus (Tamai et al.,
2000; Wehrli et al., 2000). Canonical Wnt-signaling has a pivotal role
both in the developing and mature brain. During development the
Wnt pathway regulates the balance between proliferation and differ-
entiation of neuronal progenitor and precursor cells (Noelanders &
Vleminckx, 2016). Furthermore, Wnt-signaling also affects neuronal
stem cell proliferation and differentiation in the mature brain
(Bengoa-Vergniory & Kypta, 2015), and it has a supportive role in the
maturation of dendrites and spines (Hussaini et al., 2014).
Several neurodevelopmental psychiatric disorders have been
shown to overlap not only at the behavioral levels, but also at the
genetic levels, as it has been repeatedly shown among ADHD, autism
spectrum disorder (ASD), intellectual disability (ID), bipolar disorder,
and psychosis (Brainstorm Consortium et al., 2018; Bulik-Sullivan
et al., 2015; Khanzada, Butler, & Manzardo, 2017; Polimanti & Gelern-
ter, 2017; Taurines et al., 2012; van Hulzen et al., 2017; Zhao &
Nyholt, 2017). Interestingly, the Wnt-signaling pathway seems to be
one of the overlapping pathways, showing pathological alterations in
the above disorders (Kwan, Unda, & Singh, 2016; Mulligan & Chey-
ette, 2017; Oron & Elliott, 2017; Zhao & Nyholt, 2017). For example,
genome-wide association studies (GWAS) reported the 4p15.31
region to be nominally associated with ADHD (not reaching genome-
wide p-value < 5 × 10−8), where the KCNIP4 (potassium voltage-
gated channel interacting protein 4) gene is located (Lasky-Su et al.,
2008; Lesch et al., 2008; Neale et al., 2008). KCINP4 is known to play
a role in the negative feedback loop of the Wnt/β-catenin pathway. In
a later candidate gene study, six KCNIP4 single markers and one hap-
lotype block were found to associate with adult ADHD (aADHD;
Weissflog et al., 2013). Another GWAS analyzed a subpopulation of
ADHD cases, which had concomitant oppositional defiant disorder,
and found the β-catenin-pathway to be highlighted in the enrichment
analysis (Aebi et al., 2015). Moreover, Wnt-signaling has been also
associated with learning and memory, especially with deficits in work-
ing and spatial memory (Fortress, Schram, Tuscher, & Frick, 2013;
Maguschak & Ressler, 2011; Maguschak & Ressler, 2012). Epidemio-
logical studies pointed to Wnt-involvement in behavioral problems
including hyperactivity (Hussaini et al., 2014; Maguschak & Ressler,
2012). In ASD, highly comorbid disorder in ADHD, a wide range of
evidence points to the involvement of the Wnt-pathway (Belinson
et al., 2016; Caracci, Avila, & De Ferrari, 2016; Packer, 2016; Zhang,
Yuan, Wang, & Li, 2014). Lastly, an indirect evidence of the Wnt-
signaling involvement in ADHD could be demonstrated by our
research group, showing that methylphenidate (a psychostimulant and
one of the first line treatment in ADHD therapy) influences cell prolif-
eration and differentiation supporting neuronal maturation (Grünblatt,
Bartl, & Walitza, 2018). More specifically, we could demonstrate that
methylphenidate activates Wnt-signaling, which was not due to the
dopamine transporter inhibition—the main know therapeutic mecha-
nism of this drug—as selective dopamine transporter inhibitor GBR-
12909 treatment demonstrated the opposite effects (Grünblatt
et al., 2018).
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As the two possible coreceptors LRP5 and LRP6 play major role in
Wnt-pathway activation, we conducted literature search selecting func-
tional gene variants affecting either receptor function, gene expression
or epigenetic modulations, such as histone modifications or DNA methyl-
ation levels (see Table 1 and Supporting Information Table S1). Published
genetic associations with psychiatric, neurological, or metabolic diseases
are also listed in Table 1. Based on the hypothesis of the involvement of
Wnt-signaling in ADHD, we carried out genetic association analyses of
the selected four LRP5 and LRP6 gene variants with ADHD in three inde-
pendent European samples (total 2,917 participants), and a meta-analysis
with previously published data. Furthermore, due to sex-discrepancy in
ADHD frequency, we stratified the analysis according to sex and com-
pared our results to the recent Psychiatric Genomic Consortium (PGC)
ADHD GWAS results (Demontis et al., 2017; Martin et al., 2018).
2 | METHODS
2.1 | Study samples
2.1.1 | Zurich child and adolescent ADHD (cADHD)
patients and parents including unrelated control-sample
One hundred and ninety six Caucasian nuclear families (146 families
with both parents and 50 families with one parent) were recruited and
the index patients (aged 6–21 years) were phenotypically character-
ized in the outpatient units of the Department of Child and Adoles-
cent Psychiatry and Psychotherapy, University Hospital of Psychiatry
Zurich. Families were included if at least the index patient fulfilled the
diagnostic criteria for ADHD (F90.0 or F90.1) according to ICD-10
(Dilling, Freyberger, & Stieglitz, 1996; World Health Organization,
2016). Accordingly, this resulted in 727 individuals (258 probands
with ADHD (males = 179, females = 79) and 469 controls (males =
203, females = 266); total of 382 male and 345 female participants).
The ADHD diagnoses of the parents and siblings were reported by
the parents. The psychiatric diagnostics of the index patient was
assessed by a child and adolescent psychiatrist or psychologist under
supervision of a senior psychiatrist in the clinic. The index patient was
required to be ≥6 years and to have an IQ over 75 as assessed with
either the Wechsler Intelligence Scale for Children (WISC; Tewes,
Rossmann, & Schallberger, 1999; Wechsler, 1991), the Kaufman
Assessment Battery for Children (K-ABC; Kaufman & Kaufman, 1983;
Melchers & Preuss, 1994), the Culture Fair Test (CFT-20-R; Weiss,
2006), Snijders-Oomen Nonverbal Intelligence Test (SON-R; Tellegen,
Winkel, & Laros, 2003) or Intelligence and Development Scales (IDS;
Grob, Meyer, & Hagmann-von Arx, 2009). Exclusion criteria were:
(a) potentially confounding and severe psychiatric diagnoses such as
psychosis, any pervasive developmental disorder, primary mood or
TABLE 1 Literature summary linking LRP5 and LRP6 gene variants with ADHD and other disorders
Gene SNPa
Functional effects in
HEK293T cells
Functional effects in neuronal cells or animal
models Association studies
LRP5 Loci/gene NA Overexpression of LRP5 & LRP6 in SH-SY5Y
cells protected against oxidative stress and
reduced tau phosphorylation (Zhang,
Bahety, & Ee, 2015).
BMD (Estrada et al., 2012); schizophrenia and
major depressive disorder (Zhao & Nyholt,
2017)
LRP5 rs4988319 NA NA BMD (Tran, Nguyen, Eisman, & Nguyen, 2008);
Wagner syndrome (Rothschild et al., 2013)
LRP5 rs3736228 LRP5-V1330 demonstrated
reduced Wnt3a signaling
compared to wild-type
(Urano et al., 2009)
NA Males low diastolic blood pressure (Suwazono
et al., 2006); obesity and BMI (Guo et al., 2006);
male bone fractures (van Meurs et al., 2006);
BMD (Estrada et al., 2012; Tran et al., 2008);
risk of having metabolic syndrome (Yang et al.,
2013)
LRP6 Loci/gene NA Neural tube defects in humans as well as in
mice (Allache et al., 2014; Carter et al., 2005;
Kokubu et al., 2004; Lei et al., 2015; Pinson,
Brennan, Monkley, Avery, & Skarnes, 2000);
Lrp6 mutant mice (insertion mutation)
demonstrate suboptimal development of
brain regions (e.g., forebrain, midbrain, and
hindbrain), and defected neurogenesis of
dopaminergic neurons (Castelo-Branco et al.,
2010; Pinson et al., 2000; Zhou, Zhao, &
Pleasure, 2004), as well as age-dependent
synaptic loss and memory impairments in
these mice (Liu et al., 2014)
AD, diabetes mellitus type 2, osteoporosis (Wang,
Luo, Xu, Zhou, & Zhang, 2017)
LRP6 rs1012672 LRP6-variant demonstrated
reduced Wnt signaling
compared to wild-type
(Xu et al., 2014)
NA AD (miR-141 miR-23a miR-23b; Mallick & Ghosh,
2011); AD (Alarcon et al., 2013; De Ferrari
et al., 2007)
LRP6 rs2302685 LRP6-variant demonstrated
reduced Wnt signaling
compared to wild-type
(De Ferrari et al., 2007; Xu
et al., 2014)
NA Risk of ischemic stroke (Harriott et al., 2015); AD
(Alarcon et al., 2013; De Ferrari et al., 2007);
male bone fractures (van Meurs et al., 2006)
Abbreviations: AD = Alzheimer's disease; BMD = bone mineral density; BMI = body mass index; NA = not available.
a Details on annotation, GTEx and epigenetic findings are presented in the Supporting Information Table S1.
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anxiety disorder, and Tourette's disorder, (b) neurological disorders
such as epilepsy, (c) a history of any acquired brain damage or evi-
dence of the fetal alcohol syndrome, (d) premature deliveries (delivery
before 37th gestational week), and/or (e) maternal reports of severe
prenatal, perinatal or postnatal complications.
In the case–control setting, the 196 index patients (males = 148,
females = 48) were compared to genetically independent 124 Cauca-
sian healthy controls (males = 72, females = 52, aged between 5 and
18 years) who were recruited at the Departments of Child and Ado-
lescent Psychiatry of the Universities of Würzburg and Zurich. The
index patient in the case–control study was part of the family study
and the inclusion and exclusion criteria were the same as described
above. Informed written consent was obtained in all cases from the
participants and their parents. The study was approved by the ethical
commissions of all involved universities in accordance with the latest
version of the Declaration of Helsinki, including an ethical permission
granted by the Ethic Committees from Würzburg, and the Cantonal
Ethic Committee of Zurich (Ref. Nr. KFO 140/03 and KEK-ZH-Nr.
2016–00101). Demographic characteristics of Zurich ADHD cases
and controls are summarized in Supporting Information Table S2a
and S2b.
2.1.2 | Replication samples (Hungarian and German
cADHD)
The SNP association study was replicated in samples from Budapest,
Hungary and Würzburg, Germany, which were described in detail pre-
viously (Kereszturi et al., 2007; Walitza et al., 2005). The replication
sample included child and adolescent patients with ADHD and their
parents (Würzburg; Walitza et al., 2005), and ADHD patients, their
available parents and unrelated controls (Budapest; Kereszturi et al.,
2007) with the following characteristics: There were 171 Caucasian
nuclear families (106 families with both parents and 65 families with
one parent) with additional cADHD cases and healthy young adult
controls from Budapest. In the family-based setting this yielded
181 probands with ADHD according to ICD-10 (males = 157,
females = 24) and 312 controls (males = 132, females = 180),
whereas the case–control study consisted of 206 cADHD patients
(males = 180, females = 26, aged between 5 and 17 years) and
262 healthy controls (males = 160, females = 102, aged between
18 and 29 years). The Würzburg-trios and duos included 387 children
and adolescents affected with ADHD also according to ICD-10
(males = 296, females = 91) and 540 controls (males = 275,
females = 265).
The Ethics Committees of the respective universities approved
the study and written informed consents were obtained from the par-
ticipants and their parents after the study have been fully explained
(see previous publications; Kereszturi et al., 2007; Walitza
et al., 2005).
2.1.3 | Genotyping
The study samples were genotyped for rs4988319 and rs3736228 in
LRP5, and rs1012672 and rs2302685 in LRP6, which were chosen
based on previous genetic findings (described in the introduction) and
the availability of validated or functionally tested TaqMan assays.
DNA was isolated either from whole blood collected in ethylenediami-
netetraacetic acid tubes using QIAamp DNA Blood Maxi Kit (Qiagen),
or from saliva collected in the Oragene DNA collection kit (DNA Gen-
otek, Canada) and isolated as per manufacturer's protocol. DNA con-
centrations, A260/A280, and A260/A230 ratios were measured using
a spectrophotometer (NanoVue Plus, GE). The study population was
genotyped with DNA (10 ng), TaqMan® Genotyping Master Mix
(Applied Biosystems), and LRP5 or LRP6 SNP Genotyping Assays
(Applied Biosystems—see Supporting Information Table S3) combined
in a 384-well plate. Real-time PCR was performed in a C1000™
CFX384™ Thermal cycler (Bio-Rad) using TaqMan® SNP Genotyping
Assay PCR standard protocol. Genotypes were determined by the
allelic discrimination program of Bio-Rad CFX Manager™ Software
version 2.1. Samples were run in duplicates to ensure reproducibility.
In case of ambiguity in duplicates, genotyping was repeated in a sepa-
rate run to resolve the discrepancy. No-template controls were
included in every run to exclude impurities.
2.1.4 | Statistical analysis
All association studies were run on the PLINK v1.7 (URL: http://pngu.
mgh.harvard.edu/purcell/plink/; Purcell et al., 2007). Each study group
(case–control study) was tested for Hardy–Weinberg equilibrium
(Supporting Information Table S4). For the case–control association
study, the Fisher's Exact Test was conducted and significance was set
at p < .00417 following multiple testing corrections (four SNPs, three
groups = male, female, and all together). For the family association
study, Mendel errors test (none were found) followed by the transmis-
sion disequilibrium test was conducted as well as a parent-of-origin
analysis. Power was calculated using the Genetic Association Study
(GAS) calculator http://csg.sph.umich.edu/abecasis/cats/gas_power_
calculator/index.html.
2.1.5 | Meta-analysis
We conducted literature search to find any publications that
described genetic association studies for LRP5 and LRP6 SNPs in con-
nection to ADHD or GWAS in European (Caucasian) ADHD. No previ-
ous GAS was available for these two genes in ADHD. However, we
could find the GWAS by Hinney et al. (2011), and the GWAS results
of the PGC (Demontis et al., 2017; Martin et al., 2018) containing the
SNPs analyzed in the current study. A meta-analysis was conducted
with the currently studied populations (Zurich, Budapest, and Würz-
burg) together with the cADHD results from Hinney et al. (2011)
using the MIX 2.0 Pro v.2.0.1.4 (BiostatXL, 2011. http://www.meta-
analysis-made-easy.com). The PGC-ADHD results were not added
into the meta-analysis, as the results from the PGC GWAS would out-
weigh our three study samples, due to a larger sample size, as well as
high heterogeneity since the PGC did not contain solely cADHD
patients. Therefore, the results of the PGC-ADHD were used only as
comparison to the meta-analysis results. Variability, due to between-
study heterogeneity, was estimated by I2 and funnel plots (Supporting
Information Table S5), followed by Begg's and Egger's regression test
(Begg & Mazumdar, 1994; Egger, Davey Smith, Schneider, & Minder,
1997; Supporting Information Table S6) to evaluate publication bias
due to heterogeneity, and the quality of the studies was assessed
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based on traditional epidemiological considerations as previously
described in Liu et al. (2015) (Supporting Information Table S7 and
S8). Following heterogeneity tests, fixed-effects model was used to
conduct the mea-analysis when I2 demonstrated no significant hetero-
geneity in the samples, whereas the random-effects model meta-
analysis was run if heterogeneity was found (see type of test used for
each test in Supporting Information Table S5).
2.1.6 | Gene expression patterns and functional findings
To elaborate whether the four SNPs studied may have any potential
functional effects on gene expression or epigenetic targets, the
SNPnexus (http://www.snp-nexus.org/; Chelala, Khan, & Lemoine,
2009; Dayem Ullah, Lemoine, & Chelala, 2012; Dayem Ullah,
Lemoine, & Chelala, 2013) and eQTLs for both genes according to
GTEx (https://www.gtexportal.org/home/; Consortium, 2013) were
run (see results Supporting Information Table S1). Furthermore, the
gene-expression profiles in various brain regions compared to whole
blood and nerve-tibial were extracted from GTEx data for LRP5 and
LRP6 stratified by sex. Welch two-sided t test was conducted
between the two sexes for each of the tissue analyzed. Since ADHD
is a neurodevelopmental disorder, and most likely the transcript pat-
terns alter with age, we downloaded the expression profiles of the
two genes from the BRAINSPAN consortium (http://www.brainspan.
org/) focusing on several brain regions (dorsolateral prefrontal cortex,
orbital frontal cortex, hippocampus, amygdala, striatum, and cerebel-
lum) to create age trajectories for the expression of the two genes.
3 | RESULTS
3.1 | LRP5 and LRP6 genetic associations in cADHD
Linkage disequilibrium (LD) values between the two LRP5 SNPs and
the LRP6 SNPs demonstrated weak linkage in all studied cohorts, simi-
lar to the NIH LDlink data for European populations (extracted from
https://analysistools.nci.nih.gov/LDlink/?tab=home; see Supporting
Information Table S9). Therefore, we could conclude that the resulted
association was independent of each other.
In the case–control study a nominal significant association
between LRP5 rs3736228 and ADHD was observed in the Zurich
sample (OR = 2.043, 95% CI 1.209–3.453, p = .0067, power = 0.944;
Supporting Information Table S10). This association was significant
after stratification by sex only in ADHD females (OR = 3.614, 95% CI
1.519–8.6, p = .0024, power = 1.0). Nominal significant sex-specific
association was also present at this LRP5 SNP in the Budapest case–
control sample (OR = 2.549, 95% CI 1.218–5.334, p = .0109, power =
0.995). Moreover, LRP5 rs4988319 was nominally associated with
ADHD in the female subgroup from Budapest (OR = 2.12, 95% CI
1.007–4.462, p = .0444, power = 0.923).
Although no significant association between LRP6 rs1012672 or
rs2302685 and ADHD was detected in any one of the three
European samples, some tendencies could be observed (Supporting
Information Table S10). However, following sex stratification, nominal
significant association of the LRP6 rs2302685 was observed among
males using the case–control design at both the Zurich and Budapest
ADHD samples (OR = 1.971, 95% CI 1.13–3.438, p = .0159, power =
0.904; OR = 1.516, 95% CI 1.009–2.277, p = .0441, power = 0.519,
respectively). Family based association analyses of the LRP6 SNPs
yielded only tendency toward association in the Zurich sample
(Supporting Information Table S10).
3.2 | Meta-analysis of LRP5 and LRP6 SNPs in
children and adolescents with ADHD
In order to evaluate the associations found with ADHD, we performed
a meta-analysis including both the case–control and family studies
(Zurich, Würzburg, and Budapest) with available published data from
Hinney et al. (2011). As described in the methods section, the large
PGC-ADHD GWAS (Demontis et al., 2017; Martin et al., 2018) was
not added into the current meta-analysis and was only used as a com-
parison study, because it consisted of both cADHD and aADHD, as
well as due to its weight comparing to the other studies (Supporting
Information Table S7-S8). Following heterogeneity analysis
(Supporting Information Table S5 and Figure S1) a fixed-effect model
analysis was conducted since no significant heterogeneity was
detected. At the LRP5 SNPs we could not find significant association
with cADHD (Figures 1a and 2a). On the other hand, a tendency was
observed at LRP6 rs1012672 (total n = 4,712; OR = 1.262, p = .0559,
power = 0.884; Figure 3a), and a nominal significant association was
detected at LRP6 rs2302685 with ADHD (total n = 2,917; OR =
1.206, 95% CI 1.03–1.413; p = .0197; power = 0.794; Figure 4a).
Following sex stratification, a nominal significant association of
LRP5 rs4988319 and a significant association of LRP5 rs3736228 was
observed with cADHD among females (total n = 229; OR = 1.8, 95%
CI 1.073–3.024, p = .0259, power = 0.731; total n = 957; OR =
2.083, 95% CI 1.292–3.359, p = .0026, power = 0.998; respectively;
Figures 1c and 2c). On the other hand, at LRP6 rs2303685 significant
association with cADHD was present in males (total n = 559; OR =
1.661, 95% CI 1.196–2.307, p = .0024, power = 0.846; Figure 4b).
To test the sex effect, we ran a regression analysis (generalized
linear mixed model) looking at the sex and SNP dosage and their inter-
action including the sites as a random effect in order to account for
possible site-effects. The regression analysis showed significant asso-
ciation between sex and ADHD but no significant SNP × sex interac-
tion was detected (Supporting Information Table S11). Nevertheless,
some suggestive sex effects were found supporting the meta-analysis
results, as the probability to have ADHD increased with the number
of risk allele at LRP5 rs4988319 in females (Supporting Information
Figure S2a). Similarly, a modest increase for having ADHD could be
seen for those with the risk allele of LRP5 rs3736228 (Supporting
Information Figure S2b). Whereas at LRP6 rs2302685 the probability
to have ADHD increased with the number of risk allele only in males
(Supporting Information Figure S2d).
3.3 | PGC-ADHD GWAS results for LRP5 and
LRP6 SNPs
In order to compare the current findings that focused on Caucasian
cADHD patients, we extracted the summary statistics of the newest
(November 2017) available PGC data for European ancestry ADHD
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patients (child and adolescent as well as adults) and then stratified
data by sex (Demontis et al., 2017; Martin et al., 2018). Only a sugges-
tive association was observed between ADHD and LRP5 rs3736228
among females (OR = 1.0942, 95% CI 1.0197–1.1742, p = .2779).
While, LRP6 rs2302685 showed association with ADHD only in the
female subgroup of the PGC cohort (OR = 1.177, 95% CI
1.0858–1.2503, p = .0208). Therefore, none of the associations found
in the meta-analysis could be confirmed in the PGC-ADHD data
(Supporting Information Table S10). Nevertheless, observing all SNPs'
association results of the PGC-ADHD dataset at the LRP5 gene
(Supporting Information Figure S3), a nominally significant signal could
be seen in the male/female combined population at rs4988321
(p = .032), which is in moderate LD with rs3736228 (D0 = 1.0,
R2 = 0.227 at CEU; D0 = 0.967, R2 = 0.266 at EUR) but not with
rs4988319 (D0 = 0.219, R2 = 0.009 at CEU; D0 = 0.514, R2 = 0.056 at
EUR). This association was specifically stronger (p = .0086) at the
female population in the sex stratified Manhattan plot (Supporting
Information Figure S3c). Similarly, around the studied LRP6 SNPs,
some nominally significant signals could be observed in the male/
female combined study population (Supporting Information
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FIGURE 1 Summary and meta-analysis of all cohorts and published association analyses of the LRP5 (rs4988319) gene variation with attention-
deficit hyperactivity disorder (ADHD) following sex stratification. (a) Forest plot for rs4988319 in male/female combined cohorts. (b) Forest plot
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Figure S4a), that were particularly enhanced in the stratified female
ADHD population (Supporting Information Figure S4b).
3.4 | Sex and age dependent LRP5 and LRP6 gene
expression patterns in brain tissue
According to GTEx database, LRP5 transcript expression in various brain
regions is rather low compared to the nerve-tibial, but higher than whole
blood samples (Supporting Information Figure S5). Similar pattern was
observed for LRP6 transcript with slightly higher expression levels in
brain regions (Supporting Information Figure S6). LRP5 transcript was
expressed significantly higher in male brain-spinal cord, whereas slightly
higher expression in female could be observed in the cerebellum, nucleus
accumbens, putamen, and substantia nigra, however in the last three not
reaching significance. LRP6 transcript was expressed significantly higher
in male brain-cortex, and slightly more expressed in male caudate, spinal
cord, and nerve-tibial, however not reaching significance. As the GTEx
data represents aged population, age dependent gene-expression was
extracted from the BRAINSPAN database (Supporting Information
Figure S7). From the six brain regions extracted, LRP5 and LRP6
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FIGURE 2 Summary and meta-analysis of all cohorts and published association analyses of the LRP5 (rs3736228) gene variation with attention-
deficit hyperactivity disorder (ADHD) following sex stratification. (a) Forest plot for rs3736228 in male/female combined cohorts. (b) Forest plot
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TDT = transmission disequilibrium test [Color figure can be viewed at wileyonlinelibrary.com]
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expression show a strong age dependency with higher levels at embryo-
nal and early postnatal stages compared to middle age subjects (up to
40 years of age), in which the expression becomes lower starting from
around 19 years of age (corresponding to 1,000 weeks).
4 | DISCUSSION
The involvement of Wnt-signaling in neurodevelopmental and neuro-
degenerative disorders have been widely discussed, particularly in
ASD and AD with several studies pointing to its role in cognition and
behavior (Kwan et al., 2016; Libro, Bramanti, & Mazzon, 2016; Mulli-
gan & Cheyette, 2017; Rios, Cisternas, Arrese, Barja, & Inestrosa,
2014; Wang et al., 2017; Zhang et al., 2014). In the current study, we
tested the hypothesis that LRP5 and LRP6 gene variants, coding for
essential receptors for the Wnt-pathway activation, associate with
ADHD among children and adolescents, in a sex-specific manner.
Among the four studied gene variants, our meta-analysis showed sig-
nificant association between LRP5 rs3736228 (Ala1330Val) and
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FIGURE 3 Summary and meta-analysis of all cohorts and published association analyses of the LRP6 (rs1012672) gene variation with attention-
deficit hyperactivity disorder (ADHD) following sex stratification. (a) Forest plot for rs1012672 in male/female combined cohorts. (b) Forest plot
for rs1012672 in males. (c) Forest plot for rs1012672 in females. Black whiskers in the forest plot represent 95% confidence intervals (CI) for
odds ratio; the weight of the study is reflected in symbol size. Sample demographics, individual statistics, heterogeneity, literature bias statistics,
quality assessments and scores, and type of tests was summarized in Supporting Information Tables S5–S9. Abbreviations: CC = case–control;
TDT = transmission disequilibrium test [Color figure can be viewed at wileyonlinelibrary.com]
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cADHD in girls, while LRP6 rs2303685 (Val1062Ile) was associated with
cADHD in boys. This phenomenon could also be observed in the more
heterogeneous ADHD population studied in the PGC-ADHD, consist-
ing of both cADHD and aADHD samples, in which nominally significant
SNP signals on the Manhattan plots were found to be specific for
females at LRP5, however no clear-cut result for LRP6 gene variants
emerged. This discrepancy between our results and the PGC-ADHD
might be due to higher heterogeneity observed in the PGC-ADHD
sample, considering the age of onset that may play a major role with
these gene variants. Indeed, BRAINSPAN dataset analysis (Supporting
Information Figure S7) demonstrated age-dependent gene expression
of both LRP5 and LRP6 with higher transcript levels at brain develop-
mental stages while lower in adulthood. Independent to age effects, in
GTEx dataset some hint for higher expression of LRP5 in aged females
and of LRP6 in aged males was observed (Supporting Information
Figures S5 and S6, respectively), point to sex-dependent regulation.
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quality assessments and scores, and type of tests was summarized in Supporting Information Tables S5–S9. Abbreviations: CC = case–control;
TDT = transmission disequilibrium test [Color figure can be viewed at wileyonlinelibrary.com]
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The Wnt-signaling genes were shown to display sex differences
in gene expression levels in a study of human placental transcrip-
tomics of male and female embryos (Sedlmeier et al., 2014). In this
study, the authors tested the effect of maternal dietary n-3 polyunsat-
urated fatty acid supplementation during pregnancy, measuring the
offspring's fat mass and development. Interestingly, the authors
revealed significant sex-dependent gene expression difference in con-
trol placentae per se, in which Wnt-signaling genes were down regu-
lated in male compared to female placentae (Sedlmeier et al., 2014).
Furthermore, n-3 unsaturated fatty acid supplementation affected the
placental transcriptomics much stronger in females, as demonstrated
with decreased LRP6 mRNA levels in the n-3 supplemented female
placentae (Sedlmeier et al., 2014), whereas male placenta transcrip-
tomics did not result in such alterations. In addition, the authors
showed significant positive correlation with placental estradiol-17β/
testosterone ratio and LRP6 expression (Sedlmeier et al., 2014). One
possible explanation to this sex-dimorphic effect is that there is at
least one estrogen receptor alpha response element within the gene
body of the Wnt-signaling genes, which might affect their transcrip-
tion regulation via sex hormones (Sedlmeier et al., 2014).
Lastly, some limitations should be mentioned, such as the rela-
tively modest sample size of the sex-stratified ADHD cohorts at cer-
tain gene variants in the meta-analysis, the heterogeneity of the PGC-
ADHD used as a comparison study, and the limited number of variants
studied within the two genes. Therefore, some caution should be
taken at the interpretation of our results, especially at those analyses
where only two independent study cohorts could be used. Neverthe-
less, our study's strength lies in the more homogenous, childhood-
onset ADHD samples recruited from European populations with the
same diagnostic tools and similar inclusion/exclusion criteria.
In summary, we were able to demonstrate genetic associations
between nonsynonymous LRP5 and LRP6 variants with cADHD in a
sex-specific manner. These results could highlight genetic variants
with modified receptor functions in the Wnt-signaling playing impor-
tant role in brain development and maturation, which is particularly
vulnerable in children and adolescents with ADHD. However, this
hypothesis should be further investigated at the molecular and cellular
levels, for example, using animal models or using induced pluripotent
stem cell neuronal modeling techniques. In the light of our previous
findings that methylphenidate activates Wnt-signaling (Grünblatt
et al., 2018), we suggest that LRP5/6 coreceptors could be regarded
as possible new therapeutic targets in ADHD treatment, especially in
childhood when brain maturation is still ongoing.
ACKNOWLEDGMENTS
The authors thank the families, patients, and control volunteers who
participated in this research. The authors would like to acknowledge
Psychiatric Genomics Consortium (PGC) ADHD for providing us with
the newest summary statistics of the GWAS, Ms. Miryame Hofmann
and Mrs. Susanne Kunert-Dümpelmann for their laboratory technical
support. The authors acknowledge the national grant that supported
the Hungarian study (NAP-B KTIA_NAP_13-2014-0011), the
Deutsche Forschungsgemeinschaft (DFG) grant that supported the
German study (KFO125; HE1446/9-1, HI865/2-1) and the
postdoctoral grant support for Anna Maria Werling by the University
of Zurich, the “Filling the Gap program”.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ORCID
Edna Grünblatt https://orcid.org/0000-0001-8505-7265
REFERENCES
Aebi, M., van Donkelaar, M. M., Poelmans, G., Buitelaar, J. K., Sonuga-
Barke, E. J., Stringaris, A., … van Hulzen, K. J. (2015). Gene-set and mul-
tivariate genome-wide association analysis of oppositional defiant
behavior subtypes in attention-deficit/hyperactivity disorder. American
Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 171(5),
573–588.
Alarcon, M. A., Medina, M. A., Hu, Q., Avila, M. E., Bustos, B. I., Perez-
Palma, E., … De Ferrari, G. V. (2013). A novel functional low-density
lipoprotein receptor-related protein 6 gene alternative splice variant is
associated with Alzheimer's disease. Neurobiology of Aging, 34(6),
e1709–e1718.
Allache, R., Lachance, S., Guyot, M. C., De Marco, P., Merello, E.,
Justice, M. J., … Kibar, Z. (2014). Novel mutations in Lrp6 orthologs in
mouse and human neural tube defects affect a highly dosage-sensitive
Wnt non-canonical planar cell polarity pathway. Human Molecular
Genetics, 23(7), 1687–1699.
Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of a rank
correlation test for publication bias. Biometrics, 50(4), 1088–1101.
Belinson, H., Nakatani, J., Babineau, B. A., Birnbaum, R. Y., Ellegood, J.,
Bershteyn, M., … Wynshaw-Boris, A. (2016). Prenatal beta-cate-
nin/Brn2/Tbr2 transcriptional cascade regulates adult social and ste-
reotypic behaviors. Molecular Psychiatry, 21(10), 1417–1433.
Bengoa-Vergniory, N., & Kypta, R. M. (2015). Canonical and noncanonical
Wnt signaling in neural stem/progenitor cells. Cellular and Molecular
Life Sciences, 72(21), 4157–4172.
Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K.,
Walters, R. K., et al. (2018). Science, 360(6395), pii: eaap8757. doi:
10.1126/science.aap8757.
Bulik-Sullivan, B., Finucane, H. K., Anttila, V., Gusev, A., Day, F. R.,
Loh, P. R., … Neale, B. M. (2015). An atlas of genetic correlations across
human diseases and traits. Nature Genetics, 47(11), 1236–1241.
Caracci, M. O., Avila, M. E., & De Ferrari, G. V. (2016). Synaptic Wnt/-
GSK3beta signaling hub in autism. Neural Plasticity, 2016, 9603751.
doi: 10.1155/2016/9603751.
Carter, M., Chen, X., Slowinska, B., Minnerath, S., Glickstein, S., Shi, L., …
Ross, M. E. (2005). Crooked tail (cd) model of human folate-responsive
neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-
related protein 6. Proceedings of the National Academy of Sciences of
the United States of America, 102(36), 12843–12848.
Castelo-Branco, G., Andersson, E. R., Minina, E., Sousa, K. M., Ribeiro, D.,
Kokubu, C., … Arenas, E. (2010). Delayed dopaminergic neuron differ-
entiation in Lrp6 mutant mice. Developmental Dynamics, 239(1),
211–221.
Chelala, C., Khan, A., & Lemoine, N. R. (2009). SNPnexus: A web database
for functional annotation of newly discovered and public domain single
nucleotide polymorphisms. Bioinformatics, 25(5), 655–661.
Consortium, G. T. (2013). The genotype-tissue expression (GTEx) project.
Nature Genetics, 45(6), 580–585.
Curatolo, P., D'Agati, E., & Moavero, R. (2010). The neurobiological basis
of ADHD. Italian Journal of Pediatrics, 36(1), 79.
Davies, W. (2014). Sex differences in attention deficit hyperactivity disor-
der: Candidate genetic and endocrine mechanisms. Frontiers in Neuro-
endocrinology, 35(3), 331–346.
Dayem Ullah, A. Z., Lemoine, N. R., & Chelala, C. (2012). SNPnexus: A web
server for functional annotation of novel and publicly known genetic
10 GRÜNBLATT ET AL.
variants (2012 update). Nucleic Acids Research, 40(Web Server issue),
W65–W70.
Dayem Ullah, A. Z., Lemoine, N. R., & Chelala, C. (2013). A practical guide
for the functional annotation of genetic variations using SNPnexus.
Briefings in Bioinformatics, 14(4), 437–447.
De Ferrari, G. V., Papassotiropoulos, A., Biechele, T., Wavrant De-
Vrieze, F., Avila, M. E., Major, M. B., … Moon, R. T. (2007). Common
genetic variation within the low-density lipoprotein receptor-related
protein 6 and late-onset Alzheimer's disease. Proceedings of the
National Academy of Sciences of the United States of America, 104(22),
9434–9439.
Demontis, D., Walters, R., Martin, J., Mattheisen, M., Als, T., Agerbo, E., …
Neale, B. M. (2017). Discovery of the first genome-wide significant risk
loci for ADHD. June 3, 2017 ed. bioRxiv: https://doi.org/10.1101/
145581.
Dilling, H., Freyberger, H. J., & Stieglitz, R. D. (1996). ICD-10 field trial of
the diagnostic criteria for research in German-speaking countries.
Introduction. Psychopathology, 29(5), 258–259.
Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in
meta-analysis detected by a simple, graphical test. BMJ, 315(7109),
629–634.
Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y. H., Duncan, E. L.,
Ntzani, E. E., … Rivadeneira, F. (2012). Genome-wide meta-analysis
identifies 56 bone mineral density loci and reveals 14 loci associated
with risk of fracture. Nature Genetics, 44(5), 491–501.
Fortress, A. M., Schram, S. L., Tuscher, J. J., & Frick, K. M. (2013). Canonical
Wnt signaling is necessary for object recognition memory consolida-
tion. The Journal of Neuroscience, 33(31), 12619–12626.
Grob, A., Meyer, C., & Hagmann-von Arx, P. (2009). Intelligence and Devel-
opment Scales (IDS). Intelligenz- und Entwicklungsskalen für Kinder von
5–10 Jahren. Bern: Verlag Hans Huber.
Grünblatt, E., Bartl, J., & Walitza, S. (2018). Methylphenidate enhances
neuronal differentiation and reduces proliferation concomitant to acti-
vation of Wnt signal transduction pathways. Translational Psychiatry,
8(1), 51.
Guo, Y. F., Xiong, D. H., Shen, H., Zhao, L. J., Xiao, P., Guo, Y., …
Deng, H. W. (2006). Polymorphisms of the low-density lipoprotein
receptor-related protein 5 (LRP5) gene are associated with obesity
phenotypes in a large family-based association study. Journal of Medi-
cal Genetics, 43(10), 798–803.
Harriott, A. M., Heckman, M. G., Rayaprolu, S., Soto-Ortolaza, A. I.,
Diehl, N. N., Kanekiyo, T., … Ross, O. A. (2015). Low density lipoprotein
receptor related protein 1 and 6 gene variants and ischaemic stroke
risk. European Journal of Neurology, 22(8), 1235–1241.
Hinney, A., Scherag, A., Jarick, I., Albayrak, O., Putter, C., Pechlivanis, S., …
Psychiatric GCAs. (2011). Genome-wide association study in German
patients with attention deficit/hyperactivity disorder. American Journal
of Medical Genetics. Part B, Neuropsychiatric Genetics, 156B(8),
888–897.
Hussaini, S. M., Choi, C. I., Cho, C. H., Kim, H. J., Jun, H., & Jang, M. H.
(2014). Wnt signaling in neuropsychiatric disorders: Ties with adult
hippocampal neurogenesis and behavior. Neuroscience and Biobehav-
ioral Reviews, 47, 369–383.
Kaufman, A., & Kaufman, N. (1983). K-ABC: Kaufman-assessment battery
for children. Circle Pines, MN: American Guidance Service.
Kereszturi, E., Kiraly, O., Csapo, Z., Tarnok, Z., Gadoros, J., Sasvari-
Szekely, M., & Nemoda, Z. (2007). Association between the 120-bp
duplication of the dopamine D4 receptor gene and attention deficit
hyperactivity disorder: Genetic and molecular analyses. American Jour-
nal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B(2),
231–236.
Khanzada, N. S., Butler, M. G., & Manzardo, A. M. (2017). GeneAnalytics
pathway analysis and genetic overlap among autism Spectrum disor-
der, bipolar disorder and schizophrenia. International Journal of Molecu-
lar Sciences, 18(3), 527.
Kokubu, C., Heinzmann, U., Kokubu, T., Sakai, N., Kubota, T., Kawai, M., …
Imai, K. (2004). Skeletal defects in ringelschwanz mutant mice reveal
that Lrp6 is required for proper somitogenesis and osteogenesis. Devel-
opment, 131(21), 5469–5480.
Kwan, V., Unda, B. K., & Singh, K. K. (2016). Wnt signaling networks in
autism spectrum disorder and intellectual disability. Journal of Neurode-
velopmental Disorders, 8, 45.
Lasky-Su, J., Anney, R. J., Neale, B. M., Franke, B., Zhou, K., Maller, J. B., …
Faraone, S. V. (2008). Genome-wide association scan of the time to
onset of attention deficit hyperactivity disorder. American Journal of
Medical Genetics. Part B, Neuropsychiatric Genetics, 147B(8),
1355–1358.
Lei, Y., Fathe, K., McCartney, D., Zhu, H., Yang, W., Ross, M. E., …
Finnell, R. H. (2015). Rare LRP6 variants identified in spina bifida
patients. Human Mutation, 36(3), 342–349.
Lesch, K. P., Timmesfeld, N., Renner, T. J., Halperin, R., Roser, C.,
Nguyen, T. T., … Jacob, C. (2008). Molecular genetics of adult ADHD:
Converging evidence from genome-wide association and extended
pedigree linkage studies. Journal of Neural Transmission, 115(11),
1573–1585.
Libro, R., Bramanti, P., & Mazzon, E. (2016). The role of the Wnt canonical
signaling in neurodegenerative diseases. Life Sciences, 158, 78–88.
Liu, C. C., Tsai, C. W., Deak, F., Rogers, J., Penuliar, M., Sung, Y. M., …
Bu, G. (2014). Deficiency in LRP6-mediated Wnt signaling contributes
to synaptic abnormalities and amyloid pathology in Alzheimer's dis-
ease. Neuron, 84(1), 63–77.
Liu, J., Yang, A., Zhang, Q., Yang, G., Yang, W., Lei, H., … Yu, K. (2015).
Association between genetic variants in SLC25A12 and risk of autism
spectrum disorders: An integrated meta-analysis. American Journal of
Medical Genetics. Part B, Neuropsychiatric Genetics, 168B(4), 236–246.
MacDonald, B. T., Tamai, K., & He, X. (2009). Wnt/beta-catenin signaling:
Components, mechanisms, and diseases. Developmental Cell,
17(1), 9–26.
Maguschak, K. A., & Ressler, K. J. (2011). Wnt signaling in amygdala-
dependent learning and memory. The Journal of Neuroscience, 31(37),
13057–13067.
Maguschak, K. A., & Ressler, K. J. (2012). A role for WNT/beta-catenin sig-
naling in the neural mechanisms of behavior. Journal of Neuroimmune
Pharmacology, 7(4), 763–773.
Mallick, B., & Ghosh, Z. (2011). A complex crosstalk between polymorphic
microRNA target sites and AD prognosis. RNA Biology, 8(4), 665–673.
Martin, J., Walters, R., Demontis, D., Mattheisen, M., Lee, S., Robinson, E.,
… Neale, B. M. (2018). A genetic investigation of sex bias in the preva-
lence of attention deficit hyperactivity disorder. June 15, 2018. Biol.
Psychiatry, 83(12), 1044–1053.
Melchers, P., & Preuss, U. (1994). K-ABC: Kaufman-Assessment battery for
children. Deutsche Bearbeitung. Amsterdam: Swets&Zeitglinger.
Mulligan, K. A., & Cheyette, B. N. (2017). Neurodevelopmental perspec-
tives on Wnt signaling in psychiatry. Molecular Neuropsychiatry, 2(4),
219–246.
Neale, B. M., Lasky-Su, J., Anney, R., Franke, B., Zhou, K., Maller, J. B., …
Faraone, S. V. (2008). Genome-wide association scan of attention defi-
cit hyperactivity disorder. American Journal of Medical Genetics. Part B,
Neuropsychiatric Genetics, 147B(8), 1337–1344.
Noelanders, R., & Vleminckx, K. (2016). How Wnt signaling builds the
brain: Bridging development and disease. The Neuroscientist, 23(3),
314–329.
Oron, O., & Elliott, E. (2017). Delineating the common biological pathways
perturbed by ASD's genetic etiology: Lessons from network-based
studies. International Journal of Molecular Sciences, 18(4), 828.
Packer, A. (2016). Enrichment of factors regulating canonical Wnt signaling
among autism risk genes. Molecular Psychiatry, 23(3), 492–493.
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000).
An LDL-receptor-related protein mediates Wnt signalling in mice.
Nature, 407(6803), 535–538.
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A.
(2014). ADHD prevalence estimates across three decades: An updated
systematic review and meta-regression analysis. International Journal of
Epidemiology, 43(2), 434–442.
Polimanti, R., & Gelernter, J. (2017). Widespread signatures of positive
selection in common risk alleles associated to autism spectrum disor-
der. PLoS Genetics, 13(2), e1006618.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A.,
Bender, D., … Sham, P. C. (2007). PLINK: A tool set for whole-genome
GRÜNBLATT ET AL. 11
association and population-based linkage analyses. American Journal of
Human Genetics, 81(3), 559–575.
Rios, J. A., Cisternas, P., Arrese, M., Barja, S., & Inestrosa, N. C. (2014). Is
Alzheimer's disease related to metabolic syndrome? A Wnt signaling
conundrum. Progress in Neurobiology, 121, 125–146.
Rosch, K. S., Crocetti, D., Hirabayashi, K., Denckla, M. B.,
Mostofsky, S. H., & Mahone, E. M. (2018). Reduced subcortical vol-
umes among preschool-age girls and boys with ADHD. Psychiatry
Research Neuroimaging, 271, 67–74.
Rothschild, P. R., Brezin, A. P., Nedelec, B., Burin, d., Roziers, C., Ghiotti, T.,
… Valleix, S. (2013). A family with Wagner syndrome with uveitis and a
new versican mutation. Molecular Vision, 19, 2040–2049.
Sedlmeier, E. M., Brunner, S., Much, D., Pagel, P., Ulbrich, S. E.,
Meyer, H. H., … Bader, B. L. (2014). Human placental transcriptome
shows sexually dimorphic gene expression and responsiveness to
maternal dietary n-3 long-chain polyunsaturated fatty acid intervention
during pregnancy. BMC Genomics, 15, 941.
Suwazono, Y., Kobayashi, E., Uetani, M., Miura, K., Morikawa, Y.,
Ishizaki, M., … Nogawa, K. (2006). Low-density lipoprotein receptor-
related protein 5 variant A1330V is a determinant of blood pressure in
Japanese males. Life Sciences, 78(21), 2475–2479.
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., …
He, X. (2000). LDL-receptor-related proteins in Wnt signal transduc-
tion. Nature, 407(6803), 530–535.
Taurines, R., Schwenck, C., Westerwald, E., Sachse, M., Siniatchkin, M., &
Freitag, C. (2012). ADHD and autism: Differential diagnosis or overlap-
ping traits? A selective review. Attention Deficit and Hyperactivity Disor-
ders, 4(3), 115–139.
Tellegen, P., Winkel, M., & Laros, J. (2003). Snijders Oomen Non-verbal Intel-
ligence Test Revised (SON-R). Göttingen, Germany: Hofgrefe-Verlag.
Tewes, U., Rossmann, P., & Schallberger, U. (1999). Der Hamburg-Wechsler-
Intelligenztest für Kinder (HAWIK-III)- 3. Auflage. Bern: Huber-Verlag.
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015). Preva-
lence of attention-deficit/hyperactivity disorder: A systematic review
and meta-analysis. Pediatrics, 135(4), e994–e1001.
Tran, B. N., Nguyen, N. D., Eisman, J. A., & Nguyen, T. V. (2008). Associa-
tion between LRP5 polymorphism and bone mineral density: A Bayes-
ian meta-analysis. BMC Medical Genetics, 9, 55.
Urano, T., Shiraki, M., Usui, T., Sasaki, N., Ouchi, Y., & Inoue, S. (2009).
A1330V variant of the low-density lipoprotein receptor-related protein
5 (LRP5) gene decreases Wnt signaling and affects the total body bone
mineral density in Japanese women. Endocrine Journal, 56(4), 625–631.
Van den Bergh, B. R. H., van den Heuvel, M. I., Lahti, M., Braeken, M., de
Rooij, S. R., Entringer, S., … Schwab, M. (2017). Prenatal developmental
origins of behavior and mental health: The influence of maternal stress
in pregnancy. Neuroscience and Biobehavioral Reviews, In press, doi:
10.1016/j.neubiorev.2017.07.003.
van Hulzen, K. J. E., Scholz, C. J., Franke, B., Ripke, S., Klein, M.,
McQuillin, A., … Reif, A. (2017). Genetic overlap between attention-
deficit/hyperactivity disorder and bipolar disorder: Evidence from
genome-wide association study meta-analysis. Biological Psychiatry,
82(9), 634–641.
van Meurs, J. B., Rivadeneira, F., Jhamai, M., Hugens, W., Hofman, A., van
Leeuwen, J. P., … Uitterlinden, A. G. (2006). Common genetic variation
of the low-density lipoprotein receptor-related protein 5 and 6 genes
determines fracture risk in elderly white men. Journal of Bone and Min-
eral Research, 21(1), 141–150.
Walitza, S., Renner, T. J., Dempfle, A., Konrad, K., Wewetzer, C.,
Halbach, A., … Lesch, K. P. (2005). Transmission disequilibrium of
polymorphic variants in the tryptophan hydroxylase-2 gene in
attention-deficit/hyperactivity disorder. Molecular Psychiatry, 10(12),
1126–1132.
Wang, Z. M., Luo, J. Q., Xu, L. Y., Zhou, H. H., & Zhang, W. (2017). Harnes-
sing low-density lipoprotein receptor protein 6 (LRP6) genetic variation
and Wnt signaling for innovative diagnostics in complex diseases. The
Pharmacogenomics Journal, 18(3), 351–358.
Wechsler, D. (1991). Examiner’s manual: Wechsler intelligence scale for
children—third edition. San Antonio, TX: The Psychological Corporation.
Wehrli, M., Dougan, S. T., Caldwell, K., O'Keefe, L., Schwartz, S., Vaizel-
Ohayon, D., … DiNardo, S. (2000). Arrow encodes an LDL-receptor-
related protein essential for wingless signalling. Nature, 407(6803),
527–530.
Weiss, R. (2006). Grundintelligenztest Skala 2-Revision (CFT 20-R) mit
Wortschatztest und Zahlenfolgentest—Revision (Ws/ZF-R). Göttingen,
Germany: Hofgrefe-Verlag.
Weissflog, L., Scholz, C. J., Jacob, C. P., Nguyen, T. T., Zamzow, K., Gross-
Lesch, S., … Reif, A. (2013). KCNIP4 as a candidate gene for personality
disorders and adult ADHD. European Neuropsychopharmacology, 23(6),
436–447.
World Health Organization. (2016). 10th International Classification of Dis-
eases (ICD-10). 10th revision, Geneva, Switzerland, World Health
Organization.
Xu, Y., Gong, W., Peng, J., Wang, H., Huang, J., Ding, H., & Wang, D. W.
(2014). Functional analysis LRP6 novel mutations in patients with coro-
nary artery disease. PLoS One, 9(1), e84345.
Yang, C. W., Li, C. I., Liu, C. S., Bau, D. T., Lin, C. H., Lin, W. Y., … Lin, C. C.
(2013). The joint effect of cigarette smoking and polymorphisms on
LRP5, LEPR, near MC4R and SH2B1 genes on metabolic syndrome
susceptibility in Taiwan. Molecular Biology Reports, 40(1), 525–533.
Zhang, L., Bahety, P., & Ee, P. L. (2015). Wnt co-receptor LRP5/6 overex-
pression confers protection against hydrogen peroxide-induced neuro-
toxicity and reduces tau phosphorylation in SH-SY5Y cells.
Neurochemistry International, 87, 13–21.
Zhang, Y., Yuan, X., Wang, Z., & Li, R. (2014). The canonical Wnt signaling
pathway in autism. CNS & Neurological Disorders Drug Targets, 13(5),
765–770.
Zhao, H., & Nyholt, D. R. (2017). Gene-based analyses reveal novel genetic
overlap and allelic heterogeneity across five major psychiatric disor-
ders. Human Genetics, 136(2), 263–274.
Zhou, C. J., Zhao, C., & Pleasure, S. J. (2004). Wnt signaling mutants have
decreased dentate granule cell production and radial glial scaffolding
abnormalities. The Journal of Neuroscience, 24(1), 121–126.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Sup-
porting Information section at the end of the article.
How to cite this article: Grünblatt E, Nemoda Z, Werling AM,
et al. The involvement of the canonical Wnt-signaling receptor
LRP5 and LRP6 gene variants with ADHD and sexual dimor-
phism: Association study and meta-analysis. Am J Med Genet
Part B. 2018;1–12. https://doi.org/10.1002/ajmg.b.32695
12 GRÜNBLATT ET AL.
